Evidence map›Paper›PMID 40137738›Full record

ArticlePathogens (Basel, Switzerland)2025

Emergence of Tigecycline-Nonsusceptible Carbapenem-Resistant

Yajuan Ni, Jiefu Peng, Yawen Xu, Liguo Zhu, Xiao Wang, Hui Jin, Huimin Qian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yajuan NiDepartment of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Jiefu PengDepartment of Acute Infectious Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Yawen XuYangzhou Center for Disease Control and Prevention, Yangzhou 225007, China.
Liguo ZhuDepartment of Acute Infectious Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Xiao WangXuzhou Center for Disease Control and Prevention, Xuzhou 221006, China.
Hui JinDepartment of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.ORCID 0000-0003-0071-9755
Huimin QianDepartment of Acute Infectious Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.

Funding

Special Scientific Research Fund of Yangzhou Health Commission 2023-2-33The Major National Science and Technology Projects 2018ZX10714-002The Preventive Medicine Research Project of Jiangsu Province Ym2023040
6 · The paper itself

Abstract

In recent years, resistance of

Indexed as

Anti-Bacterial AgentsAzabicyclo Compoundsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCeftazidimeDrug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaeTigecyclineCarbapenemsChinaDrug CombinationsHumansMicrobial Sensitivity TestsRetrospective StudiesAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo Compoundsbeta-LactamasesCarbapenemsCeftazidimeDrug CombinationsTigecyclinecarbapenem-resistant Klebsiella pneumoniaeceftazidime-avibactamhorizontal transfertigecycline

Identifiers

PMID40137738
PMCPMC11946248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.